NewsStackNewsStack
Daily Brief: Which companies are hyping vs delivering: red flags, real signals and repeat offenders, free daily.

SER

NYSE:SERNYSE
5 announcements
Credibility Score59%
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
Overhypeddeteriorating

Serina's losses widened as clinical trial costs rose, with cash reserves at $19.4 million.

12 Nov 2026, 21:20 UTC
▼
Serica Energy — Rig secured for multi-well UKCS drilling programme
OverhypedModerate hypeunclear

Serica secures rig for six-well UKCS campaign targeting up to 30,000 boepd from 2027.

2 Nov 2026, 07:00 UTC
▼
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
OverhypedModerate hypeunclear

Early clinical progress, but no financials or efficacy data—too soon for investment conviction.

9 Jul 2026, 16:22 UTC
▼
Gannet BioChem and Serina Therapeutics Enter Development Partnership Supporting SER-252 Program
OverhypedModerate hypeunclear

This is a hopeful partnership, but hard evidence of progress or value is missing.

30 Jun 2026, 13:07 UTC
▼